Buscar
01/04/2026
Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children
Gnech, M, Bujons, A, Radmayr, C, Hoen, L, Bogaert, G, Burgu, B, Rawashdeh, YF, Silay, MS, O'Kelly, F, Quaedackers, J, Pakkasjärvi, N, van Uitert, A, Skott, M, Kennedy, U, Yuan, YH, Zachou, A, Castagnetti, M. Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children. Journal of Pediatric Urology. 2026; 22(2)DOI:10.1016/j.jpurol.2025.06.016. PMID:40615247. IF:1.900(Q2/5D).
01/04/2026
Barriers to pregnancy and parenthood during urology residency across Europe
Afferi, L, Margue, G, Toribio-Vázquez, C, Melsert, BM, Baekelandt, L, Goujon, A, Ozalevli, M, Checcucci, E, Lazos, AG, Siech, C, Vásquez, JL, Mertens, LS, Liatsikos, E, Somani, BK, Pradere, B, Whitburn, J, Wyler, S, Breda, A, Phé, V, Weissman, JS, Rangel, E. Barriers to pregnancy and parenthood during urology residency across Europe. Bjui Compass. 2026; 7(4)DOI:10.1002/bco2.70181. PMID:42022230. IF:(Q/D).
01/04/2026
Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)
González, JG, Magaña, JG, Llàcer, P, Pal, AF, Trullàs, JC, Zegrí-Reiriz, I, Díez-Villanueva, P, Fernandez, AE, Manzano, LP, Fernández, ABM, Pérez, PC, López-Azor, JC, Martínez, R, D'Amato, M, Pascual, CF, Ruiz-Ruiz, E, Pisón, EP, Anter, MB, Marcos, MC. Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI). ESC Heart Failure. 2026; 13(2)DOI:10.1093/eschf/xvag096. PMID:41920937. IF:3.700(Q1/3D).
01/04/2026
Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Synowiec, E, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk
Vallès-Cardona, G, Caixàs, A, Berges, I, Perea, G, Vilalta, N, Corripio, R. Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk. GENETICS IN MEDICINE. 2026; 28(4)DOI:10.1016/j.gim.2026.102536. PMID:41685566. IF:6.200(Q1/1D).
01/04/2026
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Gorog, DA, ten Berg, JM, Campo, G, Geisler, T, Gigante, B, Grove, EL, Halvorsen, S, Huber, K, Jeong, YH, Lip, GYH, Navarese, EP, Rubboli, A, Matula, JMS, Storey, RF, Valgimigli, M, Vandenbriele, C, Vilahur, G, Ahrens, I, Ferreiro, JL. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuag021. PMID:41914626. IF:4.600(Q1/2D).
01/04/2026
Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction
Leader, JH, Vilahur, G, Ajjan, RA, Kanji, R, Gue, YX, Farag, M, Gorog, DA. Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction. CARDIOVASCULAR RESEARCH. 2026; 122(6)DOI:10.1093/cvr/cvag047. PMID:41757699. IF:13.300(Q1/1D).
01/04/2026
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
Marques-Pamies, M, Ricou, L, Gil, J, Sampedro-Núñez, M, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Torres, A, Librizzi, S, Calatayud, M, Novoa, PD, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Valassi, E, Puig-Domingo, M. Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study. Journal Of The Endocrine Society. 2026; 10(4)DOI:10.1210/jendso/bvag030. PMID:41798894. IF:(Q/D).